免疫检查点治疗局部晚期,持久性,复发性和转移性宫癌:系统性审查和贝叶斯网络元分析
David E Hinojosa-Gonzalez1, Jaime A Escarcega-Bordagaray2, Regina M Murillo-Torres2
1Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA.
概括
在宫癌患者中, pembrolizumab 显示出更高的整体存活率和无进展存活率. 这一元分析表明,它比其他免疫检查点抑制剂在局部晚期或晚期疾病中的优先使用.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 宫癌是全球重要的健康问题,10-30%的患者经历了治疗失败.
- 免疫检查点抑制剂 (ICI) 提供临床益处,但缺乏直接比较.
研究的目的:
- 在患有局部晚期,持续性,复发性或转移性宫癌的患者中比较各种ICI的疗效.
- 为宫癌治疗中ICI选择提供基于证据的建议.
主要方法:
- 对第三阶段随机对照试验 (RCT) 进行了系统性审查和贝叶斯网络元分析.
- 来自5项涉及3302名患者的RCT的数据被分析为总生存期 (OS) 和无进展生存期 (PFS).
- 使用积累性排名曲线 (SUCRA) 下面的表面排名来确定比较疗效.
主要成果:
- 在化学放射治疗中添加布罗利祖马布,在局部发达的宫癌中改善了OS和PFS.
- 在晚期疾病中,布罗利祖马布加化疗与其他ICI相比,显示出更高的OS和PFS,特别是与贝瓦齐祖马布结合使用时.
- 卡多尼利马布在非转移性亚组中显示出优异结局的潜力.
结论:
- 布罗利祖马布已成为改善局部晚期和晚期子宫癌的OS和PFS的主要ICI.
- 调查结果支持布罗利祖马布比其他ICI的首选使用.
- 需要进一步的对比试验来确认这些比较有效性结果.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K